Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :649
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer

Prabhash K, Medhekar A, Biswas S, Kurkure P, Nair R, Kelkar R

Year : 2009| Volume: 46| Issue : 4 | Page no: 318-322

   This article has been cited by
1 A Study on Comparative In Vitro Activity of Carbapenem Sparers Against Extended-Spectrum Beta Lactamase–Producing Enterobacteriaceae
Laxman G. Jessani,Vidyalakshmi Devarajan,Abdul Ghafur
Infectious Diseases in Clinical Practice. 2016; 24(4): 224
[Pubmed]  [Google Scholar] [DOI]
2 Comparative evaluation of the in-vitro activity of six β-lactam/β-lactamase inhibitor combinations against gram negative bacilli
Sood, S.
Journal of Clinical and Diagnostic Research. 2013; 7(2): 224-228
[Pubmed]  [Google Scholar]
3 Is screening patients for antibiotic-resistant bacteria justified in the Indian context
Bhattacharya, S.
Indian Journal of Medical Microbiology. 2011; 29(3): 213-217
[Pubmed]  [Google Scholar]
4 Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia
Sema Vural, Yildiz Yildirmak, Merve Emecen, Ela Erdem, Serap Karaman, Rejin Kebudi
Pediatric Blood & Cancer. 2011; : n/a
[HTML Full text]  [Google Scholar] [DOI]
5 Empirical versus theoretical
Shukla, S.N.
Indian Journal of Cancer. 2009; 46(4): 260-261
[Pubmed]  [Google Scholar]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow